Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations section updated to include Seoul, Korea, Republic of as a study site. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. This appears to be a minor labeling update with no changes to study content or page functionality.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding status notice was removed from the page, and this does not affect trial details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedCosmetic layout updates observed; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0.SummaryDifference4%

- Check96 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.